We are live on
!
Find out more
TAM
Tiverton Asset Management Portfolio holdings
AUM
$2.88B
1-Year Est. Return
5.6%
This Fund
S&P 500
This Quarter
Est. Return
+16.23%
1 Year Est. Return
+5.6%
3 Year Est. Return
+61.83%
5 Year Est. Return
+105.31%
10 Year Est. Return
–
AUM
$2.31B
AUM Growth
+$641M
(+38%)
Cap. Flow
+$372M
Cap. Flow
% of AUM
16.15%
Top 10 Holdings %
Top 10 Hldgs %
31.4%
Holding
680
New
190
Increased
323
Reduced
69
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$9.6M |
| 2 |
A.O. Smith
AOS
|
+$7.79M |
| 3 |
JPMorgan Chase
JPM
|
+$7.71M |
| 4 |
Microsoft
MSFT
|
+$6.58M |
| 5 |
Bank of America
BAC
|
+$6.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$7.15M |
| 2 |
Pediatrix Medical
MD
|
+$3.07M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$2.05M |
| 4 |
Wayfair
W
|
+$1.83M |
| 5 |
Arrowhead Research
ARWR
|
+$1.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.35% |
| 2 | Healthcare | 15.48% |
| 3 | Consumer Discretionary | 11.83% |
| 4 | Financials | 11.36% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Cintas
CTAS
$81.3B
| $342K | 0.01% |
+6,764
| New | +$327K |
|
|
P
452
Everpure Inc
P
$29.9B
| $342K | 0.01% |
+15,713
| New | +$299K |
|
453
HF Sinclair
DINO
$14.5B
| $341K | 0.01% |
6,929
+4,110
| +146% | +$219K |
|
454
Jabil
JBL
$35.8B
| $339K | 0.01% |
+12,747
| New | +$340K |
|
455
Okta
OKTA
$25.8B
| $339K | 0.01% |
+4,091
| New | +$324K |
|
456
Qualys
QLYS
$6.35B
| $339K | 0.01% |
4,096
+289
| +8% | +$24.1K |
|
457
FNB Corp
FNB
$6.75B
| $334K | 0.01% |
+31,511
| New | +$362K |
|
458
Trupanion
TRUP
$1.18B
| $334K | 0.01% |
+10,187
| New | +$290K |
|
459
Pilgrim's Pride
PPC
$6.54B
| $329K | 0.01% |
14,751
| – | – |
|
|
VRS
460
DELISTED
Verso Corporation
VRS
| $329K | 0.01% |
15,387
| – | – |
|
461
Best Buy
BBY
$17.3B
| $327K | 0.01% |
+4,604
| New | +$287K |
|
462
Zebra Technologies
ZBRA
$17.8B
| $327K | 0.01% |
+1,562
| New | +$294K |
|
|
UMPQ
463
DELISTED
Umpqua Holdings Corp
UMPQ
| $327K | 0.01% |
+19,833
| New | +$349K |
|
|
VMW
464
DELISTED
VMware, Inc
VMW
| $326K | 0.01% |
1,807
+45
| +3% | +$7.33K |
|
|
TBCH
465
Turtle Beach Corp
TBCH
$277M
| $324K | 0.01% |
+28,550
| New | +$430K |
|
|
AGR
466
DELISTED
Avangrid, Inc.
AGR
| $323K | 0.01% |
+6,409
| New | +$316K |
|
|
XEC
467
DELISTED
CIMAREX ENERGY CO
XEC
| $321K | 0.01% |
+4,589
| New | +$330K |
|
|
BHVN
468
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $320K | 0.01% |
6,222
| – | – |
|
469
Endava
DAVA
$156M
| $319K | 0.01% |
+11,600
| New | +$292K |
|
|
LSI
470
DELISTED
Life Storage, Inc.
LSI
| $319K | 0.01% |
+4,911
| New | +$315K |
|
471
Bank OZK
OZK
$5.61B
| $316K | 0.01% |
+10,917
| New | +$330K |
|
472
Teledyne Technologies
TDY
$32B
| $316K | 0.01% |
+1,332
| New | +$302K |
|
|
K
473
DELISTED
Kellanova
K
| $315K | 0.01% |
+5,839
| New | +$312K |
|
474
TE Connectivity
TEL
$62.6B
| $315K | 0.01% |
3,901
-663
| -15% | -$53.5K |
|
475
Littelfuse
LFUS
$11.6B
| $314K | 0.01% |
+1,720
| New | +$318K |
|
Similar funds
TAM
RCM
NA
FCM
STMM
CC
CA
BA
Tiverton Asset Management's Q1 2019 Portfolio in Review
As of Q1 2019, Tiverton Asset Management held 680 positions worth $2.31B, up 38% from $1.66B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Tiverton Asset Management deployed $372M of net new capital in Q1 2019, opening 190 new positions and adding to 323 existing holdings. Its largest new stake was Pfizer: 104,318 shares worth $4.2M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Celgene Corp, an estimated $7.15M trimmed.
- Tiverton Asset Management's largest Q1 2019 buy was Pfizer: 104,318 shares worth $4.2M.
- Tiverton Asset Management added most to Alphabet (Google) Class A in Q1 2019, an estimated $9.6M increase.
- Tiverton Asset Management's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $7.15M.
- Tiverton Asset Management fully exited Bristol-Myers Squibb in Q1 2019, selling an estimated $1.07M.
- Tiverton Asset Management's ten largest holdings make up 31% of its $2.31B portfolio in Q1 2019.
- Tiverton Asset Management opened 190 new positions and closed 28 in Q1 2019.
- Tiverton Asset Management's portfolio value rose 38% quarter-over-quarter to $2.31B.
Based on Tiverton Asset Management's 13F filing for Q1 2019, filed 13 May 2019.